Sign in to continue reading this article

Not registered? Create an account for free to read full articles on

To access full articles on, please sign in below.

Busy? Sign in Faster. Sign into with your social media account.

A 6-year-old, 19-lb (8.6-kg), indoor-only neutered male domestic shorthair cat was presented for a second opinion after being diagnosed with diabetes mellitus 10 days prior. He had a one-year history of polyuria, polydipsia, and occasional periuria. He was fed a commercial dry and canned diet twice daily, and his appetite was reportedly normal. He had a 1-lb weight loss over the past 5 months. He was up to date on rabies and FVRCP vaccinations.

Physical Examination

On examination, the patient was bright and alert. BCS was 7.5 of 9. Nonpruritic alopecia was present bilaterally over the flank and axillary regions. The hair coat was brownish-red (Figure 1), but the medical record indicated a solid black coat. Abdominal palpation elicited nonspecific pain with no noted organomegaly or masses. 

Figure 1 Flank alopecia and brownish-red hair coat of patient before adrenalectomy


CBC and serum chemistry profile showed hyperglycemia (359 mg/dL; range, 70-150 mg/dL) and mild renal azotemia (creatinine 2 mg/dL; range, 0.9-2.1 mg/dL). Urinalysis showed minimally concentrated urine (specific gravity 1.020; adequately concentrated urine [hypersthenuria] for cats is >1.035), glucosuria (4+), negative ketones, and inactive sediment. T4 was within normal limits (1.3 µg/dL; range, 0.8-4.7 µg/dL). Abdominal ultrasound findings showed a 2.5-cm-by-3-cm partially mineralized left adrenal mass and a mildly hyperechoic liver. The right adrenal gland was not visualized. Left renal nephrolithiasis and presumptive right renal compensatory hypertrophy were suggestive of chronic kidney disease. Cardiomegaly was noted on chest radiographs, and an ECG showed mild left ventricular hypertrophy. Serial systolic blood pressure measurements were consistently increased (210 mm Hg; range, 120-180 mm Hg).

A low-dose dexamethasone suppression test was performed to rule out Cushing’s disease and showed a predexamethasone suppression cortisol of 0.9 μg/dL and an 8-hour postdexamethasone suppression of 0.6 μg/dL. Adrenal panel cortisol concentrations pre-ACTH and at 30 and 60 minutes post-ACTH stimulation were 0.65 μg/dL, 1.15 μg/dL, and 1.11 μg/dL(range, 9.5-18.3 μg/dL), respectively. The panel also showed hyperestrogenemia, hyperprogesteronemia, hyperaldosteronemia, and hypocortisolemia (Table). Endogenous adrenocorticotropic hormone (ACTH) concentration measured using an assay validated for dogs and horses at Michigan State University was 2 pmol/L. The DiaSorin immunoradiometric assay is validated for use in cats for ACTH measurement, but it is not commercially available to the authors' knowledge.1,2

Endocrine Function Test Results
Endocrine Function TestsReference RangePre-adrenalectomy7 Months Postoperative10 Months Postoperative
Endogenous ACTH (pmol/L)6.7-25*285.7Not performed
Adrenal panel+
Cortisol (µg/dL) baseline0.98-5.90.654.141.48
30 minutes post-ACTH9.5-18.3*1.154.723.77
60 minutes post-ACTH9.5-18.3*1.114.724.09
Estradiol (ng/mL) baseline39-79*90.686.981.4
30 minutes post-ACTH38-70*90.886.981.4
60 minutes post-ACTH38-70*111.786.980.1
Progesterone (ng/mL) baseline0.06-0.712.50.390.22
30 minutes post-ACTH0.9-4.621.30.9†0.61
60 minutes post-ACTH0.9-4.6190.9†0.56
Aldosterone (pg/mL) baseline11.3-294.396140.714.4
30 minutes post-ACTHNo values*1226.846.629.2
60 minutes post-ACTHNo normal values provided by laboratory>139246.646.1

*ACTH reference range for dogs; range not established for cats

+Reference interval for neutered male cats

†Report did not specify whether result was 30 minutes or 60 minutes post-ACTH stimulation.

The patient remained normokalemic (4 mEq/L; range, 3.9-5.3 mEq/L) despite increased aldosterone concentration, possibly because of early disease detection, because of a compensatory decrease in urinary potassium excretion in response to hypokalemia, or secondary to kidney disease.


Diabetes mellitus and hypocortisolemia secondary to a functional adrenal tumor

This patient’s diabetes mellitus was likely caused by insulin resistance that resulted from increased progesterone. Hypocortisolemia can occur secondary to a progesterone-secreting adrenal tumor. This patient had a functional adenocarcinoma that was secreting progesterone, aldosterone, and estrogen.


Treatment with insulin glargine (Lantus, 1 unit SC q12h) and amlodipine (0.625 mg PO q24h) was initiated. Three weeks later, the patient underwent left adrenalectomy and biopsy of the liver. Histopathologic examination showed an incompletely excised, unencapsulated adrenocortical carcinoma (4 cm × 3 cm × 2.5 cm) and diffuse hepatocellular vacuolation with no evidence of neoplasia. To address the hypocortisolemia, prednisolone (5 mg PO q24h) therapy was initiated postoperatively. 


  • Surgical or laparoscopic removal of the adrenocortical tumor5
  • Postoperative administration of a physiologic dose of prednisolone (0.2 mg/kg/day PO tapered over 4-8 weeks, depending on clinical signs) to treat hypocortisolemia
  • Regular recheck examinations to monitor the patient for vomiting, diarrhea, and lethargy 
  • ACTH stimulation testing 6 weeks after prednisolone is discontinued to evaluate the ability of the remaining adrenal gland to produce cortisol


The patient’s systemic hypertension resolved with left adrenalectomy, and amlodipine was discontinued 7 days postoperatively. Diabetes mellitus resolved one month postoperatively. Prednisolone (5 mg PO q24h) was continued on a tapering schedule for 8 weeks. At the 7-month recheck appointment, the patient’s hair coat was black, and the bilateral alopecia had resolved (Figure 2). Abdominal ultrasonography disclosed a right adrenal gland measuring 5 mm by 4 mm with normal echogenicity and contour. The increased size most likely was caused by compensatory hyper-trophy and increased ACTH concentration. Endogenous ACTH concentration was markedly increased (85.7 pmol/L; range, 6.7-25 pmol/L) as compared with preadrenalectomy concentration (2 pmol/L). Serum estradiol concentration remained high.

Figure 2 Seven months postadrenalectomy, the patient’s alopecia has resolved and the hair coat color has returned to black.

A mild increase in baseline estradiol was detected 7 months postoperatively, and estradiol concentration post-ACTH stimulation was decreased at both 7-month and 10-month recheck examinations. Because less than 1% of estradiol is secreted by the adrenal gland and most estradiol is secreted by peripheral tissue, the persistently high estradiol concentration may not have been representative of adrenal activity.3 Hyperprogesteronemia and hyperaldosteronemia were resolved at subsequent follow-up examinations (Table). The patient continued to do well postoperatively for approximately 6 years until he was euthanized because of congestive heart failure.


Adrenocortical carcinomas secreting aldosterone and progesterone or other steroid sex hormones in cats have been reported.4,5 This case is unusual because the adrenocortical carcinoma secreted at least 3 different types of steroid hormones, and the patient had dermatologic abnormalities (ie, symmetric alopecia, hair coat color change).

Symmetric alopecia has been reported in cats with progesterone-secreting adrenal tumors and in cats treated with progestin injections (ie, medroxyprogesterone acetate).6-8 Carbohydrate intolerance is a common result of progesterone-mediated insulin antagonism in cats and is likely a causal factor for diabetes mellitus.8,9

Lightening of the hair coat from black to red has been observed in some canine endocrinopathies, including Sertoli cell tumors, Cushing’s disease, and hypothyroidism.6 In cats, reddening of the hair coat appears to be less common. The hair coat color change in this patient, which resolved postadrenalectomy, may have been caused by increased estradiol concentration or may have occurred secondary to low ACTH concentration. Estrogen has been reported to cause increased hair pigmentation in mice,10 and a recent case report described a cat with hypocortisolemia and subtle hair coat color changes that resolved with removal of an estrogen-secreting adrenal tumor.2

Alternatively, low ACTH concentration leading to low α-melanocyte-stimulating hormone (MSH) concentration might have been involved in the coat color change. ACTH is a precursor of α-MSH, and both share a common amino acid sequence. A decrease in ACTH production would indirectly decrease the α-MSH concentration. ACTH and α-MSH are both full agonists of the melanocortin-1 receptor (MC1R).11

Activation of MC1R on melanocytes leads to production of eumelanin (black-brown pigment), whereas inhibition of MC1R results in production of pheomelanin (yellow-red pigment). Low concentrations of both ACTH and α-MSH would decrease MC1R binding and subsequently decrease synthesis of eumelanin and increase synthesis of pheomelanin.6,11 The opposite occurs in humans with Addison’s disease; hyperpigmentation caused by increased ACTH concentration is a common finding in these patients.12

The relationship between low ACTH and cortisol concentrations and sex hormone-secreting adrenal tumors is poorly understood. Possible causes include negative feedback of cortisol from increased displacement of free cortisol from cortisol-binding protein by sex hormones and negative feedback of ACTH from progesterone or unmeasured intermediate metabolites.4,7,9 Exogenous progestins such as megestrol acetate have been shown to suppress endogenous ACTH secretion.7,13 All of these sources can result in hypocortisolemia caused by suppression of the hypothalamic–pituitary–adrenal axis.


  • In cats with adrenomegaly or an adrenal gland tumor, endocrine function tests should be performed to look for other endocrine abnormalities if low-dose dexamethasone suppression and ACTH stimulation testing fail to demonstrate increased cortisol concentration. 
  • In cats with symmetric nonpruritic trunk alopecia and/or poorly controlled diabetes mellitus, endocrine function tests can help detect underlying endocrine imbalances (eg, hyperprogesteronemia).
  • Endogenous ACTH concentration should be interpreted with hair coat color changes, as low serum concentration of ACTH may be associated with lightening of hair color. 
  • Hypocortisolemia may occur after unilateral adrenalectomy because of atrophy of the contralateral adrenal gland from chronic negative feedback of the functional adrenocortical tumor.

ACTH = adrenocorticotropic hormone, MC1R = melanocortin-1 receptor, MSH = melanocyte-stimulating hormone

References and author information Show
  1. Eiler KC, Bruyette DS, Behrend EN, Kemppainen RJ, Kass PH. Comparison of intravenous versus intramuscular administration of corticotropin-releasing hormone in healthy cats. J Vet Intern Med. 2013;27(3):516-521.
  2. Nadolski AC, Markovich JE, Jennings SH, Mahony OM. Mammary development, hyperestrogenemia, and hypocortisolemia in a male cat with an adrenal cortical carcinoma. Can Vet J. 2016;57(10):1077-1080.
  3. Engelking LR. Testosterone, estrogen and progesterone. In: Engelking LR. Metabolic and Endocrine Physiology. 3rd ed. Jackson, WY: Teton New Media; 2012:120.
  4. Daniel G, Mahony OM, Markovich JE, et al. Clinical findings, diagnostics, and outcome in 33 cats with adrenal neoplasia (2002-2013). J Feline Med Surg. 2016;18(2):77-84.
  5. Lo AJ, Holt DE, Brown DC, Schlicksup MD, Orsher RJ, Agnello KA. Treatment of aldosterone-secreting adrenocortical tumors in cats by unilateral adrenalectomy: 10 cases (2002-2012). J Vet Intern Med. 2014;28(1);137-143.
  6. Miller WH, Griffin CE, Campbell KL. Muller & Kirk’s Small Animal Dermatology. 7th ed. St. Louis, MO: Elsevier Mosby; 2013. 
  7. Rossmeisl JH Jr, Scott-Moncrieff JC, Siems J, et al. Hyperadrenocorticism and hyperprogesteronemia in a cat with an adrenocortical adenocarcinoma. J Am Anim Hosp Assoc. 2000;36(6):512-517.
  8. Boord M, Griffin C. Progesterone secreting adrenal mass in a cat with clinical signs of hyperadrenocorticism. J Am Vet Med Assoc. 1999;214(5):666-669.
  9. Feldman EC, Nelson RW. Canine and Feline Endocrinology and Reproduction. 3rd ed. St Louis, MO: Elsevier Saunders; 2004:325-357, 394-439. 
  10. Hirobe T, Kiuchi M, Wakamatsu K, Ito S. Estrogen increases hair pigmentation in female recessive yellow mice. Zoolog Sci. 2010;27(6):470-476. 
  11. Wolf Horrell EM, Boulanger MC, D’Orazio JA. Melanocortin 1 receptor: structure, function, and regulation. Front Genet. 2016;7:95.
  12. Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet. 2014;383(9935):2152-2167.
  13. Church DB, Watson ADJ, Emslie DR, Middleton DJ, Tan K, Wong D. Effects of proligestone and megestrol on plasma adrenocorticotrophic hormone, insulin, and insulin-like growth factor-1 concentrations in cats. Res Vet Sci. 1994;56(2):175-178.

Mei Lun Mui

DVM Cummings School of Veterinary Medicine at Tufts University

Mei Lun Mui, DVM, is a small animal rotating intern at University of Pennsylvania. She earned her DVM from Cummings School of Veterinary Medicine at Tufts University and her BS in brain, behavior, and cognitive science from University of Michigan. Dr. Mui will pursue a small animal internal medicine residency next year and board certification in small animal internal medicine.

Orla Mahony

MVB, DACVIM & DECVIM Tufts University Cummings School of Veterinary Medicine

Orla Mahony, MVB, DACVIM & DECVIM, is clinical assistant professor in the department of small animal clinical sciences at Tufts University Cummings School of Veterinary Medicine, where she performed her residency in internal medicine. Endocrinology is her primary clinical interest. She received her veterinary degree from University College Dublin.

Lluís Ferrer

DVM, PhD, DECVD Tufts Cummings School of Veterinary Medicine

Lluís Ferrer, DVM, PhD, DECVD, is professor of veterinary dermatology at Tufts Cummings School of Veterinary Medicine. Dr. Ferrer’s research focuses on canine leishmaniasis, canine AD, canine demodicosis, and the use of stem cells as a therapy in veterinary dermatology. He earned his DVM and PhD at the University of Zaragoza (Spain).

Material from Clinician’s Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.

Up Next